Clinical trials: Microdosing
Pain, Intractable, Pain, Back
BurstDR™ micrOdosing stimuLation in De-novo Patients
The purpose of this study is to evaluate the therapeutic efficacy of microdosing BurstDR stimulation in spinal cord stimulation (SCS) patients with chronic intractable back and/or leg pain.
- Trial name
- BOLD (NCT03350256)
- Testing
- Stimulation will be delivered at with different microdosing setting to identify the optimal parameter values for each patient.
- Where
- 5 sites in United States
- Volunteers
- 60 people
- Sponsor
- Abbott Medical Devices